New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to ...

Critics will argue that double-blind placebo-controlled trials provide more reliable information than real-world clinical ...

Ken Wallace, MBA, is president, Clinical Trial Marketing Communications (CTMC), and through a joint venture, vice president of operations, Integrated Clinical Trial Services (ICTS).

With a commitment to process optimization, training, and audits to enhance their operations, CROs can ensure the integrity of medications throughout the trial process. [Adobe Stock ...

Breaking Down the Clinical Trial Process. Clinical trials are the backbone of modern oncology, often determining the most effective primary treatment for various types of cancer.

A four-year-old London startup backed by Peter Thiel has raised a $55 million Series B round as it sets about “fixing the broken clinical trial industry.” The announcement comes as artificial ...

AI-driven text analytics can revolutionise the clinical trial process by improving data collection and analysis in the biopharma industry. Learn how this technology can enhance efficiency and ...

The development of new medications is a long, complex, and costly process. Productivity—how efficiently a drug developer creates value from their investment—is key to success, yet it often ...

In today’s globalized pharma environment, technical and supply chain challenges in the clinical trial process create ripple effects felt by stakeholders across regions and functions.

Melvin Mann, diagnosed with chronic myeloid leukemia in 1994, participated in a clinical trial for Imatinib that extended his life by 30 years.

ORLANDO, Fla. — Explaining the details of the clinical trial process is critical to minimizing barriers to research participation, according to a presenter at the 2024 Rheumatology Nurses ...

Discover what clinical trials are, why they're vital for new treatments, and how you can participate in life-changing medical research.